Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey.
Kristian Steen FrederiksenThomas R NielsenIldebrando AppollonioBirgitte Bo AndersenMario RiverolMercè BoadaMathieu CeccaldiBruno DuboisSebastiaan EngelborghsLutz FrölichLucrezia HausnerAudrey GabelleTomasz GabryelewiczTimo GrimmerBernard HanseeuwJakub HortJacques HugonVesna JelicAnne KoivistoMilica G KrambergerThibaud LebouvierAlberto LleóAlexandre de MendonçaFlavio NobiliPierre-Jean OussetRobert PerneczkyMarcel Olde RikkertDavid RobinsonOlivier RouaudElisabet SánchezIsabel SantanaNikolaos ScarmeasKaterina SheardovaStephanie SloanLuiza SpiruElka StefanovaLatchezar TraykovGörsev YenerGunhild WaldemarPublished in: International journal of geriatric psychiatry (2020)
The variability in clinical practices across centers calls for better biomarker counseling and better training to improve communication skills. Future initiatives should address the importance of communicating preventive strategies and advance planning.